RE: US$ Exchange Rate29 Sep 2022 13:04
Just confirmed who bough the 25k shares yesterday;
NEW YORK, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (NASDAQ:TLSA) ("Tiziana" or the "Company"), a biotechnology company enabling breakthrough immunotherapies via novel routes of drug delivery, today announces that it has been notified that Matthew Davis, its Chief Medical Officer, purchased 25,000 common shares at $0.75 per share, bringing his total holding to 200,000 common shares.